These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33207935)

  • 1. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
    Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
    JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
    Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters.
    Raskind MA; Williams T; Holmes H; Hart K; Crews L; Poupore EL; Thomas RG; Darnell J; Daniels C; Goke K; Hendrickson R; Terry G; Mayer C; Simpson T; Saxon A; Rasmussen D; Peskind ER
    Alcohol Clin Exp Res (Hoboken); 2023 Feb; 47(2):348-360. PubMed ID: 36809662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Prazosin on Provoked Alcohol Craving and Autonomic and Neuroendocrine Response to Stress in Alcohol Use Disorder.
    Milivojevic V; Angarita GA; Hermes G; Sinha R; Fox HC
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1488-1496. PubMed ID: 32449942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol craving and withdrawal at treatment entry prospectively predict alcohol use outcomes during outpatient treatment.
    Martins JS; Fogelman N; Wemm S; Hwang S; Sinha R
    Drug Alcohol Depend; 2022 Feb; 231():109253. PubMed ID: 34998258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Initiating Abstinence from Alcohol on Daily Craving and Negative Affect: Results from a Pharmacotherapy Clinical Trial.
    Hallgren KA; Delker BC; Simpson TL
    Alcohol Clin Exp Res; 2018 Mar; 42(3):634-645. PubMed ID: 29286542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder.
    Simpson TL; Saxon AJ; Stappenbeck C; Malte CA; Lyons R; Tell D; Millard SP; Raskind M
    Am J Psychiatry; 2018 Dec; 175(12):1216-1224. PubMed ID: 30153753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
    Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial.
    Simpson TL; Achtmeyer C; Batten L; Reoux J; Shofer J; Peskind ER; Saxon AJ; Raskind MA
    Alcohol Alcohol; 2024 Jul; 59(5):. PubMed ID: 39270736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol withdrawal symptoms predict corticostriatal dysfunction that is reversed by prazosin treatment in alcohol use disorder.
    Sinha R; Fogelman N; Wemm S; Angarita G; Seo D; Hermes G
    Addict Biol; 2022 Mar; 27(2):e13116. PubMed ID: 34856641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trial.
    Aubin HJ; Berlin I; Guiraud J; Bruhwyler J; Batel P; Perney P; Trojak B; Bendimerad P; Guillou M; Bisch M; Grall-Bronnec M; Labarrière D; Delsart D; Questel F; Moirand R; Bernard P; Trovero F; Pham HP; Tassin JP; Puech A
    Addiction; 2024 Jul; 119(7):1211-1223. PubMed ID: 38597214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder.
    Wilcox CE; Tonigan JS; Bogenschutz MP; Clifford J; Bigelow R; Simpson T
    J Addict Med; 2018; 12(5):339-345. PubMed ID: 29664896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
    Furieri FA; Nakamura-Palacios EM
    J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
    Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
    Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
    Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
    Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecamylamine treatment for alcohol dependence: a randomized controlled trial.
    Petrakis IL; Ralevski E; Gueorguieva R; O'Malley SS; Arias A; Sevarino KA; Jane JS; O'Brien E; Krystal JH
    Addiction; 2018 Jan; 113(1):6-14. PubMed ID: 28710873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
    Rose AK; Jones A
    Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.